Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Epidemiological profile of tuberculosis in Iraq during 2011-2018.

Autor: Ali ZA; Biotechnology Department, College of Science, University of Baghdad, Baghdad, Iraq., Al-Obaidi MJ; Tropical-Biological Research Unit, College of Science, University of Baghdad, Baghdad, Iraq., Sameer FO; Tropical-Biological Research Unit, College of Science, University of Baghdad, Baghdad, Iraq., Mankhi AA; National Specialized Center for Chest and Respiratory Diseases, Ministry of Health and Environment, Baghdad, Iraq., Misha'al KI; Tropical-Biological Research Unit, College of Science, University of Baghdad, Baghdad, Iraq., Jassim IA; Tropical-Biological Research Unit, College of Science, University of Baghdad, Baghdad, Iraq., Taqi EA; Tropical-Biological Research Unit, College of Science, University of Baghdad, Baghdad, Iraq., Ad'hiah AH; Tropical-Biological Research Unit, College of Science, University of Baghdad, Baghdad, Iraq. Electronic address: dr.a.h.adhiah@gmail.com.

Publikováno v: The Indian journal of tuberculosis [Indian J Tuberc] 2022 Jan; Vol. 69 (1), pp. 27-34. Date of Electronic Publication: 2021 Jan 19.

Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study.

Autor: Goswami P; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom., Oliva EN; Haematology Unit, Grande Ospedale Metropolitano, Reggio Calabria, Italy., Ionova T; St. Petersburg State University Medical Center and Multinational Centre for Quality of Life Research, St. Petersburg, Russia., Else R; Patient Research Partner, Milton Keynes, United Kingdom., Kell J; Cardiff and Vale University Health Board, Cardiff, United Kingdom., Fielding AK; University College London Cancer Institute, London, United Kingdom., Jennings DM; Royal Surrey County Hospital NHS Foundation Trust, Guildford, United Kingdom., Karakantza M; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom., Al-Ismail S; Singleton Hospital, ABM University Health Board, Swansea, United Kingdom., Collins GP; Oxford University Hospitals NHS Trust, Oxford, United Kingdom., McConnell S; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom., Langton C; Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom., Al-Obaidi MJ; West Middlesex University Hospital, Isleworth, United Kingdom., Oblak M; West Middlesex University Hospital, Isleworth, United Kingdom., Salek S; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, United Kingdom.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2020 Sep 08; Vol. 11, pp. 1308. Date of Electronic Publication: 2020 Sep 08 (Print Publication: 2020).

Clinical proof of concept for a safe and effective NF-κB-targeting strategy in multiple myeloma.

Autor: Tornatore L; CCSI, Department of Medicine, Imperial College London, London, UK., Capece D; CCSI, Department of Medicine, Imperial College London, London, UK., D'Andrea D; CCSI, Department of Medicine, Imperial College London, London, UK., Begalli F; CCSI, Department of Medicine, Imperial College London, London, UK., Verzella D; CCSI, Department of Medicine, Imperial College London, London, UK., Bennett J; CCSI, Department of Medicine, Imperial College London, London, UK., Acton G; Cancer Research UK Centre for Drug Development, London, UK., Campbell EA; C&C Management Consulting Ltd, Exmouth, UK., Kelly J; Alpha Preclinical Consultancy, Halifax, UK., Tarbit M; Independent Consultant, Royston, UK., Adams N; In2Phase Ltd, Welwyn Garden City, UK., Bannoo S; CCSI, Department of Medicine, Imperial College London, London, UK., Leonardi A; Department of Molecular Medicine, University of Naples Federico II, Naples, Italy., Sandomenico A; IBB-CNR and CIRPeB, 'Federico II' University of Naples, Naples, Italy., Raimondo D; Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Ruvo M; IBB-CNR and CIRPeB, 'Federico II' University of Naples, Naples, Italy., Chambery A; DiSTABiF, University of Campania 'Luigi Vanvitelli', Caserta, Italy., Oblak M; West Middlesex University Hospital, Isleworth, Greater London, UK., Al-Obaidi MJ; Haematology Department, Chelsea and Westminster Hospital, London, UK., Kaczmarski RS; London Haematology Limited, London, UK., Gabriel I; Haematology Department, Chelsea and Westminster Hospital, London, UK., Oakervee HE; Barts Cancer Centre, St Bartholomew's Hospital London, London, UK., Kaiser MF; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Wechalekar A; Royal Free London NHS Foundation Trust, London, UK., Benjamin R; Department of Haematology, King's College Hospital, London, UK., Apperley JF; Centre for Haematology, Imperial College London, London, UK., Auner HW; Centre for Haematology, Imperial College London, London, UK.; Cancer Cell Protein Metabolism, Department of Medicine, Imperial College London, London, UK., Franzoso G; CCSI, Department of Medicine, Imperial College London, London, UK.

Publikováno v: British journal of haematology [Br J Haematol] 2019 May; Vol. 185 (3), pp. 588-592. Date of Electronic Publication: 2018 Sep 26.

Challenging blood transfusion practice: effect of targeted behavioural intervention on red cell transfusion in a district general hospital.

Autor: Warburton KG; Hammersmith Hospital, London, UK., Chituku M; West Middlesex University Hospital NHS Trust, Isleworth, UK., Ballard K; West Middlesex University Hospital NHS Trust, Isleworth, UK., Al-Obaidi MJ; West Middlesex University Hospital NHS Trust, Isleworth, UK.

Publikováno v: Future hospital journal [Future Hosp J] 2016 Oct; Vol. 3 (3), pp. 169-173.